Clôture précédente | 217,18 |
Ouverture | 218,52 |
Offre | 216,93 x 800 |
Vente | 217,25 x 800 |
Var. jour | 215,26 - 221,53 |
Sur 52 semaines | 173,45 - 371,16 |
Volume | |
Volume moyen | 1 361 867 |
Cap. boursière | 34,021B |
Bêta (mensuel sur 5 ans) | 1,15 |
Rapport P/E (sur 12 mois) | S.O. |
BPA (sur 12 mois) | S.O. |
Date de bénéfices | S.O. |
Dividende et rendement à terme | S.O. (S.O.) |
Date ex-dividende | S.O. |
Objectif sur 1 an | S.O. |
Before next-generation sequencing (NGS) came along, children and families with rare and undiagnosed genetic diseases often faced years-long diagnostic odysseys.
While visiting her grandparents in Florida, 17-year-old Kate frequented a pond near their house and spent time observing the various species of fish living there.
NORTHAMPTON, MA / ACCESSWIRE / November 8, 2022 / Illumina: At the Phoenix Convention Center in Arizona, representatives from Illumina, a global leader in DNA sequencing and array-based technologies, joined approximately 2000 molecular diagnostic ...